Exelixis (EXEL) Change in Accured Expenses (2010 - 2026)

Exelixis' (EXEL) quarterly Change in Accured Expenses came in at $4.0 million in Q2 2026, down 12.18% year-on-year from $4.6 million in Q2 2025, and up 1039.15% quarter-over-quarter from $355000.0 in Q1 2026.

Exelixis (EXEL) Change in Accured Expenses (2010 - 2026) Analysis & Trends

Exelixis' Change in Accured Expenses history runs 16 years deep, the most recent figure standing at $4.0 million for Q2 2026.

  • On a quarterly basis, Change in Accured Expenses fell 12.18% year-over-year to $4.0 million in Q2 2026; TTM through Apr 2026 was $1.3 million, a 83.85% decrease from a year earlier, with the FY2026 full-year figure at $1.9 million, up 1374.5% from the prior year.
  • Change in Accured Expenses climbed to $4.0 million in Q2 2026 per EXEL's latest filing, from $355000.0 in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $5.1 million in Q2 2023 and bottomed at -$54.3 million in Q2 2022.
  • The 5-year median for Change in Accured Expenses is $604500.0 (2025), against an average of -$3.4 million.
  • Across the five-year window, Change in Accured Expenses plunged 5499.1% in 2022 and jumped 223.48% in 2025, its largest moves.
  • Year by year, Change in Accured Expenses stood at -$54.3 million in 2022, then soared by 100.49% to $264000.0 in 2023, then jumped by 410.23% to $1.3 million in 2024, then plunged by 32.96% to $903000.0 in 2025, then soared by 347.84% to $4.0 million in 2026.
  • Per Business Quant, the three latest EXEL Change in Accured Expenses figures stand at $4.0 million (Q2 2026), $355000.0 (Q1 2026), and $903000.0 (Q4 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 1.13 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -16.82 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 23.10 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 107.70 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -16.74 Mn
10 Exelixis 14.38 Bn 13.60 Bn 590.86 Mn 4.04 Mn

Historic Data

Download Data
DateValue
Apr 3, 2026 4.04 Mn
Apr 3, 2026 4.04 Mn
Jan 2, 2026 355,000.00
Jan 2, 2026 355,000.00
Oct 3, 2025 903,000.00
Oct 3, 2025 903,000.00
Jul 4, 2025 -3.96 Mn
Jul 4, 2025 -3.96 Mn
Apr 4, 2025 4.61 Mn
Apr 4, 2025 4.61 Mn
Jan 3, 2025 854,000.00
Jan 3, 2025 854,000.00
Sep 27, 2024 1.35 Mn
Sep 27, 2024 1.35 Mn
Jun 28, 2024 1.48 Mn
Jun 28, 2024 1.48 Mn
Mar 29, 2024 -3.83 Mn
Mar 29, 2024 -3.83 Mn
Dec 29, 2023 264,000.00
Dec 29, 2023 264,000.00